WPCT.L Share News (WPCT)

CORRECT (June 8): Syncona, Woodford And Arix Investee Plans ADS Offer

(Correcting Syncona and Woodford's shareholding value in Autolus Therapeutics following the ADS offering)LONDON (Alliance News) - Healthcare investor Syncona Ltd said Friday that its an

Woodford Patient Capital Net Asset Value Falls As Prothena Trial Fails

LONDON (Alliance News) - FTSE 250-listed Woodford Patient Capital Trust's net asset value for 2017 dropped as one of its portfolio companies Prothena Corp, reported a failed trial of one of in

Woodford Patient Investee Prothena Reports Disappointing Trial Results

LONDON (Alliance News) - Woodford Patient Capital Trust PLC said Monday that investee Prothena Corp PLC's trial investigating NEOD001 for treating AL Amyloidosis has not met its primary trust

BP Marsh Has Strong February After Positive Results - QuotedData

LONDON (Alliance News) - Net asset value moves during February were a result of dollar strength rather than a change in the local currency value of assets, according to a by a

Assets fall significantly at Woodford Patient Capital Trust

(ShareCast News) - Woodford Patient Capital Trust announced its unaudited half-yearly financial report for the period from 1 January to 30 June on Thursday, with net assets falling to £717.89m from £814.86m a year ago. The FTSE 250 firm's net asset value fell to 86.81p from 101.86p, while its share

Gold Funds Rally In June But UK Funds Stung By Brexit - QuotedData

Best And Worst Performing London-Listed Funds In June - QuotedData

UK Dividends Calendar - Next 7 Days

Woodford Patient Capital To Pay 2015 Dividend As Net Asset Value Slips

Woodford Patient Capital Trust declines in maiden results

(ShareCast News) - Neil Woodford's latest investment vehicle Woodford Patient Capital Trust saw net asset value fall during 2015, by 2.6% to 97.38p, it reported in its maiden results on Tuesday. The FTSE 250 company nonetheless described its investment opportunities as "better, deeper and richer" th

Imperial Innovations Takes Part In MISSION Therapeutics Funding Round

Woodford Patient Capital Eyes Further Capital Raising (ALLISS)

PRESS: Woodford Calls For Break-Up Of GlaxoSmithKline - BBC

Estate Agency Purplebricks Trades 6% Lower On First Day On AIM (ALLIPO)

Neil Woodford Sells Out Of Rolls-Royce After Losing Confidence (ALLISS)